• Home
  • About
  • Contact Us
  • Home
  • About
  • Contact Us
Attention Pharmalot readers… We are moving to Stat!
November 13, 2015 3:58 PM
pic thx to jd hancock on flickr creative commons

pic thx to jd hancock on flickr creative commons

Dear Pharmalot folks:

After weeks of planning, Pharmalot will be moving to Stat, the smashing new life sciences site, on Monday, Nov. 16. What does this mean? Well, all future posts – including our weekly column, which also runs in The Boston Globe – will appear on Stat, instead of this location.

For those of you looking for a quick way to access Pharmalot stuff specifically, you can also go to this tab on Stat.

There is one caveat. For now, the recent stories that we published on this site will continue to be housed here, but eventually they will migrate to Stat as well. We apologize for any inconvenience. Some things take time, you know?

As our grandmother taught us, the only constant is change. But this can be a good thing. We want to thank you for your loyalty and hope you’ll follow us to Stat. See you there…

Print This Post Print This Post
PharmalotStatThe Boston Globe
Share

Uncategorized

Ed Silverman

  • About Pharmalot

    Pharmalot is produced by Stat, a national publication from Boston Globe Media Partners that will launch online this fall with coverage of health, medicine and life sciences. Learn more and sign up for exclusive content at www.statnews.com, where Pharmalot will move after the launch.

    Ed Silverman, a senior writer at Stat, has covered the pharmaceutical industry for two decades and has closely followed the many hurdles facing drug makers as they move ideas from the laboratory to the medicine chest. He has previously worked at The Wall Street Journal, The Star-Ledger of New Jersey, New York Newsday and Investor’s Business Daily. Feel free to send tips and suggestions to ed.silverman@statnews.com Follow us on Twitter @Pharmalot and @StatNews. And sign up for the Stat newsletter here.
  • Categories

    • AIDS
    • Alzheimer's
    • Antibiotics
    • Antitrust
    • Biosimilars
    • Bribes
    • Cancer
    • Cholesterol
    • Clinical Trials
    • Compound Pharmacies
    • Counterfeit Medicines
    • Diabetes
    • Direct-to-Consumer Advertising
    • Drug Development
    • Executive Hiring
    • FDA
    • FTC
    • Generics
    • Hepatitis C
    • Insider Trading
    • Laboratory Tests
    • Layoffs
    • Legislation
    • Litigation
    • Marketing
    • Medicaid
    • Mergers and Acquisitions
    • Off-Label Promotion
    • Off-Label Promotoin
    • Over-the-Counter Medicines
    • Painkillers
    • Patents
    • Patient Privacy
    • Patient Safety
    • Pharmacy Benefit Managers
    • Pricing & Patient Access
    • Product Recall
    • Quality Control
    • Rare Diseases
    • Research & Development
    • Schizophrenia
    • Side Effects
    • Uncategorized
    • Vaccines
    • Whistleblower


© Copyright Pharmalot 2015. All Rights Reserved.